Marilyn S. Campbell

Omega-3 Fatty Acids Reduce Adipose Tissue Macrophages in Human Subjects With Insulin Resistance

Fish oils (FOs) have anti-inflammatory effects and lower serum triglycerides. This study examined adipose and muscle inflammatory markers after treatment of humans with FOs and measured the effects of ω-3 fatty acids on adipocytes and macrophages in vitro. Insulin-resistant, nondiabetic subjects were treated with Omega-3-Acid Ethyl Esters (4 g/day) or placebo for 12 weeks. Plasma macrophage chemoattractant protein 1 (MCP-1) levels were reduced by FO, but the levels of other cytokines were unchanged. The adipose (but not muscle) of FO-treated subjects demonstrated a decrease in macrophages, a decrease in MCP-1, and an increase in capillaries, and subjects with the most macrophages demonstrated the greatest response to treatment. Adipose and muscle ω-3 fatty acid content increased after treatment; however, there was no change in insulin sensitivity or adiponectin. In vitro, M1-polarized macrophages expressed high levels of MCP-1. The addition of ω-3 fatty acids reduced MCP-1 expression with no effect on TNF-α. In addition, ω-3 fatty acids suppressed the upregulation of adipocyte MCP-1 that occurred when adipocytes were cocultured with macrophages. Thus, FO reduced adipose macrophages, increased capillaries, and reduced MCP-1 expression in insulin-resistant humans and in macrophages and adipocytes in vitro; however, there was no measureable effect on insulin sensitivity.

The emerging role of curcumin for improving vascular dysfunction: A review

ABSTRACT Curcumin, when administered in a bioavailable form, has potential to influence vascular health of various populations, leading to decreases in cardiovascular disease risk. Clinical intervention studies with curcumin have demonstrated significant improvements in endothelial function, arterial compliance, arterial stiffness, and other measures of vascular hemodynamics in young, middle-aged, old, post-menopausal, healthy, diabetic, and obese individuals. Mechanistically, curcumin is believed to improve vascular function through its effects on inflammation, oxidative stress, nitric oxide bioavailability, and structural proteins of the artery. Current data give support for curcumin to be administered for improvements in vascular health to individuals that may or may not be at risk for cardiovascular disease. This review briefly summarizes the techniques used for the establishment of vascular health and overviews the literature investigating the role of curcumin in the improvement of vascular health.

An Incentivized, Workplace Physical Activity Intervention Preferentially Increases Daily Steps in Inactive Employees:

Although physical activity (PA) is associated with decreased risk of chronic diseases, fewer than half of American adults meet the recommendations for daily PA, in part, due to large amounts of sedentary time in the workplace. Purpose: To determine the efficacy of an incentivized workplace PA intervention. Design: Retrospective cohort design. Setting: Large southeastern university. Participants: Of the 16 588 eligible employees working ≥8 h/wk, 6246 (37.6%) participated and 2206 (13.3%) were included in data analysis. Intervention: Six-week PA intervention with tiered incentives (value:

Sweet potato (Ipomoea batatas) attenuates diet-induced aortic stiffening independent of changes in body composition

10.50-

The Effect of Curcumin on Cardiovascular Health in Obese Men

29.00). Measures: Steps/day measured via consumer-grade PA monitors for 1-week pre-, 6-weeks during, and 1-week postintervention. Analysis: Participants were grouped by preintervention PA into 4 groups: <6000 (I); 6000 to 7999 (II); 8000 to 9999 (III); and ≥10 000 (IV) steps/d (n = 481, 540, 485, and 700, respectively) in accordance with the tiered incentive schedule. Statistical comparisons were made by repeated-measures analysis of variance. Results: During the intervention, participants achieving ≥10 000 steps/d increased by 60%. Groups I, II, and III significantly increased steps/day during the intervention (46%, 24%, and 11%, respectively), which was partially maintained in groups I and II 1-week postintervention. Group IV did not increase steps/day during the intervention and significantly decreased steps/day 1-week postintervention. The estimated cost per participant of this intervention increased with from group I (

Responsiveness to curcumin intervention is associated with reduced aortic stiffness in young, obese men with higher initial stiffness

55.41) to IV (

Whole grain consumption is negatively correlated with obesity-associated aortic stiffness: A hypothesis

71.90). Conclusion: An incentivized, workplace PA intervention preferentially increases PA and is most cost-effective among university employees with low initial PA who may benefit substantially from increased levels of PA.

Palmitate and oleate co-treatment increases myocellular protein content via impaired protein degradation

We hypothesized a sweet potato intervention would prevent high-fat (HF) diet-induced aortic stiffness, which would be associated with decreased arterial oxidative stress and increased mitochondrial uncoupling. Young (8-week old) C57BL/6J mice were randomly divided into 4 groups: low fat (LF; 10% fat), HF (60% fat), low-fat sweet potato (LFSP; 10% fat containing 260.3 μg/kcal sweet potato), or high-fat sweet potato diet (HFSP; 60% fat containing 260.3 μg/kcal sweet potato) for 16 weeks. Compared with LF and LFSP, HF- and HFSP-fed mice had increased body mass and percent fat mass with lower percent lean mass (all, P < 0.05). Sweet potato intervention did not influence body composition (all, P > 0.05). Arterial stiffness, assessed by aortic pulse wave velocity and ex vivo mechanical testing of the elastin region elastic modulus (EEM) was greater in HF compared with LF and HFSP animals (all, P < 0.05). Advanced glycation end products and nitrotyrosine abundance were greater in aortic segments from HF mice compared with LF and HFSP animals (all, P < 0.05). Aortic elastin and uncoupling protein 2 expressions, however, were reduced in HF compared with LF and HFSP mice (all, P < 0.05). Aortic segments cultured with 2,4-dinitrophenol (DNP), a mitochondrial uncoupler, for 72 h reduced the EEM of HF arteries compared with nontreated HF segments (P < 0.05). DNP had no effect on the EEM of aortic segments from HFSP mice. In conclusion, sweet potato attenuates diet-induced aortic stiffness independent of body mass and composition, which is associated with a normalization of arterial oxidative stress possibly due to mitochondrial uncoupling.

Curcumin Supplementation Decreases Homocysteine and Increases HDL in Young, Obese Men: 2924 Board #207 June 1 3

OF DISSERTATION THE EFFECT OF CURCUMIN ON CARDIOVASCULAR HEALTH IN OBESE MEN Cardiovascular disease is the leading cause of death in the United States, and conventional treatment often emphasizes pharmaceutical approaches. Research has recently started exploring non-pharmaceutical approaches, including nutritional interventions. This research study was conducted to test the effectiveness of a novel nutritional approach, curcumin, on the improvement of cardiovascular health in young, obese males (BMI≥30 kg/m2). This study included 22 men, matched based on BMI and randomly assigned to the intervention (n=11) or placebo group (n=11). The intervention consisted of 12 weeks of curcumin supplementation (1.0 g/day) with fenugreek added to enhance the curcumin bioavailability; the placebo consisted of 12 weeks of equal parts fenugreek to that found in the intervention. To determine cardiovascular improvements, arterial stiffness via gold-standard carotid-femoral pulse wave velocity (cfPWV), endothelial dysfunction via reactive hyperemia index (RHI), and inflammation via plasma cytokine concentrations were measured. There were no overall differences in cfPWV (p=0.428) or RHI (p=0.951) between groups following the 12 weeks of intervention. However, some individuals did respond to the curcumin treatment with reductions in cfPWV, while others did not. Subjects who did respond to the curcumin treatment (n=6) entered the study with higher baseline values of cfPWV than those that did not respond (n=5) (6.81 m/s v. 5.84 m/s, p = 0.045). This suggests a potential role for curcumin to improve arterial stiffness in individuals with stiffer arteries at baseline. A possible mechanism to explain the difference in responsiveness is a trending increase in IL-13 (p=0.052), an anti-inflammatory cytokine that has been associated with amelioration of collagen content in the arteries. Also, 12 weeks of curcumin intervention resulted in reductions in brachial pulse pressure (p<0.05), a surrogate marker of arterial stiffness. This change in brachial pulse pressure in the curcumin group could be explained by an increased trend in anti-inflammatory cytokine IL-10 (p=0.071), but further studies are required to confirm this finding. Based on the findings of this study, curcumin might serve as a non-pharmaceutical intervention to improve vascular health in young obese men, especially when arteries are stiffer than age-matched counterparts.